Patients with multiple sclerosis found to have gut microbe changes

June 29, 2016 by Bob Yirka, Medical Xpress report

Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia
(Medical Xpress)—A team of researchers with Brigham and Women's Hospital at Harvard Medical School has discovered that people with multiple sclerosis appear to have differences in their gut biome than the rest of the population. In their paper published in the journal Nature Communications, the researchers describe testing they undertook of patients that had MS and of others in a control group, and the differences they found in levels of gut microbes between the two.

Multiple sclerosis (MS) is an incurable progressive disease that involves erosion of the myelin sheathing that covers nerve cells in the brain and spinal column. Patients who have it typically experience numbness in limbs, speech deterioration, problems with muscle control, trouble with vision and chronic fatigue. Prior research has suggested that it is an auto-immune disease –in this new effort, the researchers looked to the biome to determine if any changes might be present for those with the disease, because other auto-immune disease have been found to do so.

To find out, the researchers collected fecal samples from 63 people known to have MS, along with 43 samples from people without the disease. In studying the samples, the researchers found no measurable differences in overall biome diversity, but they did find elevated numbers of two types of bacteria—Methanobrevibacter and Akkermansia. To make sure the elevations were not due to medications given to MS patients, the team split the initial samples into two groups, those that had been treated with drugs, and those that had not. Both groups were found to have elevated levels of the bacteria—they also noted that both groups also had a slight decline in Butyricimonas.

The researchers then conducted a profile of related genes in T-cells looking for connections to the changes in the gut biome and found that there was a relationship between them and activation of interferon and other inflammatory pathways—the levels of which were consistent with the degree of bacterial gut level increases.

Finally, the team analyzed breath samples that had also been taken from all the patients and controls and found slightly elevated levels of methane in MS patients, which made sense, because the types of bacteria with elevated levels found in their biomes, were the type that are known to produce methane in the gut.

Intestinal microbiome composition from healthy controls (HC), untreated MS patients (MS-U), and MS patients on disease modifying therapy (MS-Tr) measured on two different high-throughput DNA sequencing platforms, Roche 454 and Illumina MiSeq. Credit: Howard Weiner, Brigham and Women's Hospital

The results of the study suggest that biome testing could become a new means of testing for MS, charting its progression, or perhaps even as part of the development of drugs meant to treat it.

Explore further: Children with and without multiple sclerosis have differences in gut bacteria

More information: Sushrut Jangi et al. Alterations of the human gut microbiome in multiple sclerosis, Nature Communications (2016). DOI: 10.1038/ncomms12015

Abstract
The gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Patients on disease-modifying treatment show increased abundances of Prevotella and Sutterella, and decreased Sarcina, compared with untreated patients. MS patients of a second cohort show elevated breath methane compared with controls, consistent with our observation of increased gut Methanobrevibacter in MS in the first cohort. Further study is required to assess whether the observed alterations in the gut microbiome play a role in, or are a consequence of, MS pathogenesis.

Press release

Related Stories

Children with and without multiple sclerosis have differences in gut bacteria

May 16, 2016
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease. Certain types of bacteria were either more or less abundant in children with ...

Researchers find link between gut bacteria and MS

June 27, 2016
If asked to list problems that bad gut bacteria can cause, most would likely name digestive issues: constipation, excessive gas, or diarrhea.

Researchers identify genes associated with specific metabolic pathways

October 2, 2015
(Medical Xpress)—An international team of researchers working at the Washington University School of Medicine in Missouri has identified several genes associated with specific metabolic pathways in a mammal biome, including ...

Exploring the gut-brain connection for insights into multiple sclerosis

May 9, 2016
New research by investigators at Brigham and Women's Hospital (BWH) suggests that bacteria living in the gut may remotely influence the activity of cells in the brain that are involved in controlling inflammation and neurodegeneration. ...

Indicator of chronic fatigue syndrome found in gut bacteria

June 27, 2016
Physicians have been mystified by chronic fatigue syndrome, a condition where normal exertion leads to debilitating fatigue that isn't alleviated by rest. There are no known triggers, and diagnosis requires lengthy tests ...

Gut microbiome of mother found to impact immunity of mice pups

March 18, 2016
(Medical Xpress)—A team of researchers from Switzerland and Germany has found that the gut microbiome of a pregnant mouse can have an impact on the development of the immune system in the pups she delivers. In their paper ...

Recommended for you

Stem cell researchers develop promising technique to generate new muscle cells in lab

December 12, 2018
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared ...

Gut hormone increases response to food

December 12, 2018
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty ...

New mouse model may speed identification of promising muscular dystrophy therapies

December 12, 2018
A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.